Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
2007 1
2008 1
2010 1
2011 4
2012 5
2013 14
2014 10
2015 11
2016 11
2017 21
2018 11
2019 9
2020 9
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32188650

96 results
Results by year
Filters applied: . Clear all
Page 1
The role of complement in kidney disease.
Willows J, Brown M, Sheerin NS. Willows J, et al. Clin Med (Lond). 2020 Mar;20(2):156-160. doi: 10.7861/clinmed.2019-0452. Clin Med (Lond). 2020. PMID: 32188650 Free PMC article.
Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.
Nester CM, Brophy PD. Nester CM, et al. Curr Opin Pediatr. 2013 Apr;25(2):225-31. doi: 10.1097/MOP.0b013e32835df4a3. Curr Opin Pediatr. 2013. PMID: 23486421 Review.
Early treatment with eculizumab in atypical haemolytic uraemic syndrome.
Garjau M, Azancot M, Ramos R, Sánchez-Corral P, Montero MA, Serón D. Garjau M, et al. Clin Kidney J. 2012 Feb;5(1):31-3. doi: 10.1093/ndtplus/sfr157. Epub 2012 Jan 31. Clin Kidney J. 2012. PMID: 26069743 Free PMC article.
Evolving complexity of complement-related diseases: C3 glomerulopathy and atypical haemolytic uremic syndrome.
Cook HT. Cook HT. Curr Opin Nephrol Hypertens. 2018 May;27(3):165-170. doi: 10.1097/MNH.0000000000000412. Curr Opin Nephrol Hypertens. 2018. PMID: 29517501 Free article. Review.
An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S. Campistol JM, et al. Nefrologia. 2015;35(5):421-47. doi: 10.1016/j.nefro.2015.07.005. Epub 2015 Oct 9. Nefrologia. 2015. PMID: 26456110 Free article. English, Spanish.
Complement and glomerular disease: new insights.
Pickering M, Cook HT. Pickering M, et al. Curr Opin Nephrol Hypertens. 2011 May;20(3):271-7. doi: 10.1097/MNH.0b013e328345848b. Curr Opin Nephrol Hypertens. 2011. PMID: 21422921 Review.
Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome.
Durán CE, Blasco M, Maduell F, Campistol JM. Durán CE, et al. Clin Kidney J. 2012 Feb;5(1):28-30. doi: 10.1093/ndtplus/sfr107. Epub 2012 Jan 28. Clin Kidney J. 2012. PMID: 26069742 Free PMC article.
Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
Mallett A, Hughes P, Szer J, Tuckfield A, Van Eps C, Cambell SB, Hawley C, Burke J, Kausman J, Hewitt I, Parnham A, Ford S, Isbel N. Mallett A, et al. Intern Med J. 2015 Oct;45(10):1054-65. doi: 10.1111/imj.12864. Intern Med J. 2015. PMID: 26247170
Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
Okumi M, Tanabe K. Okumi M, et al. Nephrology (Carlton). 2016 Jul;21 Suppl 1:9-13. doi: 10.1111/nep.12776. Nephrology (Carlton). 2016. PMID: 26988663 Review.
Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature.
Manenti L, Gnappi E, Vaglio A, Allegri L, Noris M, Bresin E, Pilato FP, Valoti E, Pasquali S, Buzio C. Manenti L, et al. Nephrol Dial Transplant. 2013 Sep;28(9):2246-59. doi: 10.1093/ndt/gft220. Epub 2013 Jun 19. Nephrol Dial Transplant. 2013. PMID: 23787552 Review.
96 results
Jump to page
Feedback